ZFIN ChEBI: N-acylpiperazine

Relationships

is a type of: amide piperazines

amide piperazines Show first 5 Terms
has subtype: (2R)-4-[(6-chloronaphthalen-2-yl)sulfonyl]-1-[(5-methyl-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridin-2-yl)carbonyl]piperazine-2-carboxamide 1-(phenanthren-2-ylcarbonyl)piperazine-2,3-dicarboxylic acid 1-[(6-chloronaphthalen-2-yl)sulfonyl]-4-[(1-pyridin-4-ylpiperidin-4-yl)carbonyl]piperazine 1-[4-(1-oxoprop-2-enyl)-1-piperazinyl]-2-propen-1-one 1-acetyl-4-(4-{4-[(2-ethoxyphenyl)thio]-3-nitrophenyl}pyridin-2-yl)piperazine ... Show All 44 Terms

(2R)-4-[(6-chloronaphthalen-2-yl)sulfonyl]-1-[(5-methyl-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridin-2-yl)carbonyl]piperazine-2-carboxamide 1-(phenanthren-2-ylcarbonyl)piperazine-2,3-dicarboxylic acid 1-[(6-chloronaphthalen-2-yl)sulfonyl]-4-[(1-pyridin-4-ylpiperidin-4-yl)carbonyl]piperazine 1-[4-(1-oxoprop-2-enyl)-1-piperazinyl]-2-propen-1-one 1-acetyl-4-(4-{4-[(2-ethoxyphenyl)thio]-3-nitrophenyl}pyridin-2-yl)piperazine 1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine 2-[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]-1-(8-methyl-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)ethanone 2-[4-(4-bromophenyl)sulfonyl-1-piperazinyl]-N-[(4-chloro-3-nitrophenyl)methylideneamino]acetamide 2-[4-(phenylmethyl)-1-piperazinyl]-N-(thiophen-2-ylmethylideneamino)acetamide 2-[4-[(2-chlorophenyl)methyl]-1-piperazinyl]-N-[3-(2-nitrophenyl)prop-2-enylideneamino]acetamide 2-[4-[(4-chlorophenyl)methyl]-1-piperazinyl]-N-(pyridin-4-ylmethylideneamino)acetamide 2-{(2R)-4-[2-(1H-imidazol-1-yl)-6-methylpyrimidin-4-yl]-1-isobutyrylpiperazin-2-yl}-N-[2-(4-methoxyphenyl)ethyl]acetamide 3-[(2S)-3-(4-beta-alanylpiperazin-1-yl)-3-oxo-2-{[(2,4,6-triisopropylphenyl)sulfonyl]amino}propyl]benzenecarboximidamide 3-{(2S)-2-[(2-naphthylsulfonyl)amino]-3-oxo-3-piperazin-1-ylpropyl}benzenecarboximidamide 3-{(2S)-3-(4-acetylpiperazin-1-yl)-2-[(2-naphthylsulfonyl)amino]-3-oxopropyl}benzenecarboximidamide 4-({(2R,5S)-2,5-dimethyl-4-[(2R)-3,3,3-trifluoro-2-hydroxy-2-methylpropanoyl]piperazin-1-yl}carbonyl)benzonitrile 5-{[4-(9H-fluoren-9-yl)piperazin-1-yl]carbonyl}-1H-indole benzyl {(1S)-5-amino-1-[(S)-hydroxy(5-{[4-(4-phenylbutanoyl)piperazin-1-yl]methyl}-1,2,4-oxadiazol-3-yl)methyl]pentyl}carbamate delavirdine doxazosin erastin gartisertib GSK1016790A LB42908 ML-210 N'-[(6-oxo-5-prop-2-enyl-1-cyclohexa-2,4-dienylidene)methyl]-2-[4-(phenylmethyl)-1-piperazinyl]acetohydrazide N-(4-{1-[4-(4-acetylpiperazin-1-yl)-trans-cyclohexyl]-4-amino-1H-pyrazolo[3,4-d]pyrimidin-3-yl}-2-methoxyphenyl)-1-methyl-1H-indole-2-carboxamide N-[(2-furanylmethylamino)-oxomethyl]-2-[4-(2-phenylethenylsulfonyl)-1-piperazinyl]acetamide N-[[3-(2-furanyl)-2-methylprop-2-enylidene]amino]-2-[4-(phenylmethyl)-1-piperazinyl]acetamide N-carbonylpiperazine N-sulfonylpiperazine nigerazine A nigerazine B nigragillin olaparib pipobroman piposulfan SCH772984 smoothib sotorasib SU11274 talmapimod torin 1 zavegepant Show first 5 Terms

Phenotype

Phenotype resulting from N-acylpiperazine

Phenotype where environments contain N-acylpiperazine

Phenotype modified by environments containing N-acylpiperazine

Human Disease Model